References
1. Momtazmanesh S, Moghaddam SS, Ghamari S-H, et al. 2023. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. eClinicalMedicine 59: 101936
2. Global Asthma Network. 2022. The Global Asthma Report. The International Journal of Tuberculosis and Lung Disease 26(Supp 1): 1-104
3. Haughney J, Winders TA, Holmes S, et al. 2020. Global quality standard for identification and management of severe asthma. Advances in Therapy 37(9): 3645-59
4. Jo EJ, Kim MY, Kim SH, et al. 2020. Implementation of asthma management guidelines and possible barriers in Korea. Journal of Korean Medical Science 35(12): e72
5. Nunes C, Pereira AM, Morais-Almeida M. 2017. Asthma costs and social impact. Asthma Research and Practice 3: 1
6. Song HJ, Blake KV, Wilson DL, et al. 2020. Medical costs and productivity loss due to mild, moderate, and severe asthma in the United States. Journal of Asthma and Allergy 13: 545-55
7. Hekking PW, Wener RR, Amelink M, et al. 2015. The prevalence of severe refractory asthma. Journal of Allergy and Clinical Immunology 135(4): 896-902
8. Roche N, Garcia G, Larrard Ad, et al. 2022. Real-life impact of uncontrolled severe asthma on mortality and healthcare use in adolescents and adults: findings from the retrospective, observational RESONANCE study in France. British Medical Journal Open 12(8): e060160
9. Chung KF, Wenzel SE, Brozek JL, et al. 2014. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. European Respiratory Journal 43(2): 343-73
10. Asthma + Lung UK. 2020. Falling into isolation: Lived experience of people with severe asthma. London: Asthma + Lung UK
11. Global Initiative for Asthma (GINA). 2023. Global strategy for asthma management and prevention. Fontana, WI: GINA
12. Foster JM, McDonald VM, Guo M, et al. 2017. “I have lost in every facet of my life”: The hidden burden of severe asthma. European Respiratory Journal 50(3): 1700765
13. Wang E, Wechsler ME, Tran TN, et al. 2020. Characterization of severe asthma worldwide. Chest 157(4): 790-804
14. Scelo G, Torres-Duque CA, Maspero J, et al. 2024. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry. Annals of Allergy, Asthma and Immunology 132(1): 42-53
15. Shaw DE, Sousa AR, Fowler SJ, et al. 2015. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. European Respiratory Journal 46(5): 1308-21
16. Sadatsafavi M, Lynd L, Marra C. 2010. Direct health care costs associated with asthma in British Columbia. Canadian Respiratory Journal 17(2): 74-80
17. Rupani H, Rose J, Cumella A, et al. 2022. P145 What is the severe asthma patient journey to biologic initiation in UK severe asthma centres? Thorax 77(Suppl 1): A159-A60
18. Asthma + Lung UK. 2019. Living in limbo: The scale of unmet need in difficult and severe asthma. London: Asthma + Lung UK
19. Menzies-Gow A, Jackson DJ, Al-Ahmad M, et al. 2022. A renewed charter: Key principles to improve patient care in severe asthma. Advances in Therapy 39(12): 5307-26
20. Price DB, Trudo F, Voorham J, et al. 2018. Adverse outcomes from initiation of systemic corticosteroids for asthma: Long-term observational study. Journal of Asthma and Allergy 11: 193-204
21. Gonzalez de la Fuente A, Wait S. 2023. A breath of fresh air: Addressing missed opportunities in severe asthma care. London: The Health Policy Partnership
Z4-62664 Date of Preparation: May 2024
